Intercept Pharmaceuticals Inc (NASDAQ:ICPT)

71.07
Delayed Data
As of May 25
 +1.31 / +1.88%
Today’s Change
51.05
Today|||52-Week Range
135.59
+21.65%
Year-to-Date
No recent news for Intercept Pharmaceuticals Inc.

Today’s Trading

Previous close69.76
Today’s open69.72
Day’s range69.07 - 71.39
Volume267,682
Average volume (3 months)791,774
Market cap$2.1B
Data as of 4:00pm ET, 05/25/2018

Growth & Valuation

Earnings growth (last year)+14.10%
Earnings growth (this year)+20.47%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)+424.85%
P/E ratioNM
Price/Sales11.18
Price/Book110.15

Competitors

 Today’s
change
Today’s
% change
MDCOMedicines Co+1.04+3.26%
AGIOAgios Pharmaceutical...+0.74+0.84%
SAGESAGE Therapeutics In...-2.84-1.80%
PBHPrestige Brands Hold...+0.74+2.18%
Data as of 4:01pm ET, 05/25/2018

Financials

Next reporting dateJuly 3, 2018
EPS forecast (this quarter)-$2.95
Annual revenue (last year)$131.0M
Annual profit (last year)-$360.4M
Net profit margin-275.18%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Mark E. Pruzanski
Chief Operating Officer
Jerome B. Durso
Corporate headquarters
New York, New York

Forecasts